Klingelnberg AG
Klingelnberg AG (KLIN.SW) Stock Competitors & Peer Comparison
See (KLIN.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KLIN.SW | CHF 12.85 | -1.15% | 113.6M | 12.12 | CHF 1.06 | +3.85% |
| GE.SW | CHF 152.00 | +4.11% | 164.8B | 48.56 | CHF 3.13 | +0.18% |
| SCHN.SW | CHF 286.50 | +0.00% | 31.4B | 31.24 | CHF 9.17 | +2.03% |
| SCHP.SW | CHF 295.20 | -0.34% | 31.3B | 32.16 | CHF 9.18 | +2.03% |
| VACN.SW | CHF 287.50 | -2.14% | 8.6B | 38.69 | CHF 7.43 | +2.13% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +1.86% |
| KGX.SW | CHF 57.36 | N/A | 7.5B | 14.42 | CHF 3.98 | +1.55% |
| SUN.SW | CHF 157.20 | -0.25% | 5.3B | 20.58 | CHF 7.64 | +2.70% |
| GF.SW | CHF 63.95 | -2.44% | 5.2B | 21.60 | CHF 2.96 | +2.06% |
| BUCN.SW | CHF 385.00 | -0.39% | 3.9B | 17.44 | CHF 22.07 | +2.85% |
Stock Comparison
KLIN.SW vs GE.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, GE.SW has a market cap of 164.8B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while GE.SW trades at CHF 152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas GE.SW's P/E ratio is 48.56. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to GE.SW's ROE of +0.26%. Regarding short-term risk, KLIN.SW is less volatile compared to GE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check GE.SW's competition here
KLIN.SW vs SCHN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, SCHN.SW has a market cap of 31.4B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while SCHN.SW trades at CHF 286.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas SCHN.SW's P/E ratio is 31.24. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to SCHN.SW's ROE of +0.15%. Regarding short-term risk, KLIN.SW is more volatile compared to SCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check SCHN.SW's competition here
KLIN.SW vs SCHP.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, SCHP.SW has a market cap of 31.3B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while SCHP.SW trades at CHF 295.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas SCHP.SW's P/E ratio is 32.16. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to SCHP.SW's ROE of +0.15%. Regarding short-term risk, KLIN.SW is more volatile compared to SCHP.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check SCHP.SW's competition here
KLIN.SW vs VACN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, VACN.SW has a market cap of 8.6B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while VACN.SW trades at CHF 287.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas VACN.SW's P/E ratio is 38.69. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to VACN.SW's ROE of +0.30%. Regarding short-term risk, KLIN.SW is less volatile compared to VACN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check VACN.SW's competition here
KLIN.SW vs RAA.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to RAA.SW's ROE of +0.31%. Regarding short-term risk, KLIN.SW is more volatile compared to RAA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check RAA.SW's competition here
KLIN.SW vs KGX.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, KGX.SW has a market cap of 7.5B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while KGX.SW trades at CHF 57.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas KGX.SW's P/E ratio is 14.42. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to KGX.SW's ROE of +0.03%. Regarding short-term risk, KLIN.SW is more volatile compared to KGX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check KGX.SW's competition here
KLIN.SW vs SUN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, SUN.SW has a market cap of 5.3B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while SUN.SW trades at CHF 157.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas SUN.SW's P/E ratio is 20.58. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to SUN.SW's ROE of +0.22%. Regarding short-term risk, KLIN.SW is more volatile compared to SUN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check SUN.SW's competition here
KLIN.SW vs GF.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, GF.SW has a market cap of 5.2B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while GF.SW trades at CHF 63.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas GF.SW's P/E ratio is 21.60. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to GF.SW's ROE of +3.63%. Regarding short-term risk, KLIN.SW is less volatile compared to GF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check GF.SW's competition here
KLIN.SW vs BUCN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, BUCN.SW has a market cap of 3.9B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while BUCN.SW trades at CHF 385.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas BUCN.SW's P/E ratio is 17.44. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to BUCN.SW's ROE of +0.12%. Regarding short-term risk, KLIN.SW is more volatile compared to BUCN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check BUCN.SW's competition here
KLIN.SW vs JUNGH.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to JUNGH.SW's ROE of +0.16%. Regarding short-term risk, KLIN.SW is more volatile compared to JUNGH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check JUNGH.SW's competition here
KLIN.SW vs KU2.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, Volatility data is not available for a full comparison. KLIN.SW has daily volatility of 2.33 and KU2.SW has daily volatility of N/A.Check KU2.SW's competition here
KLIN.SW vs BCHN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, BCHN.SW has a market cap of 2.5B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while BCHN.SW trades at CHF 726.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas BCHN.SW's P/E ratio is 23.28. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to BCHN.SW's ROE of +0.34%. Regarding short-term risk, KLIN.SW is more volatile compared to BCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check BCHN.SW's competition here
KLIN.SW vs KARN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, KARN.SW has a market cap of 2.4B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while KARN.SW trades at CHF 314.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas KARN.SW's P/E ratio is 32.24. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to KARN.SW's ROE of +0.28%. Regarding short-term risk, KLIN.SW is less volatile compared to KARN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check KARN.SW's competition here
KLIN.SW vs WAF.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, WAF.SW has a market cap of 2.2B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while WAF.SW trades at CHF 71.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas WAF.SW's P/E ratio is 6.86. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to WAF.SW's ROE of +0.02%. Regarding short-term risk, KLIN.SW is more volatile compared to WAF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check WAF.SW's competition here
KLIN.SW vs INRN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, INRN.SW has a market cap of 1.9B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while INRN.SW trades at CHF 2,290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas INRN.SW's P/E ratio is 30.30. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to INRN.SW's ROE of +0.14%. Regarding short-term risk, KLIN.SW is less volatile compared to INRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check INRN.SW's competition here
KLIN.SW vs OERL.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, OERL.SW has a market cap of 1.3B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while OERL.SW trades at CHF 3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas OERL.SW's P/E ratio is 19.94. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to OERL.SW's ROE of +0.06%. Regarding short-term risk, KLIN.SW is less volatile compared to OERL.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check OERL.SW's competition here
KLIN.SW vs BLD.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to BLD.SW's ROE of -0.41%. Regarding short-term risk, KLIN.SW is more volatile compared to BLD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check BLD.SW's competition here
KLIN.SW vs BYS.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, BYS.SW has a market cap of 822.9M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while BYS.SW trades at CHF 402.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas BYS.SW's P/E ratio is -13.97. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to BYS.SW's ROE of -0.10%. Regarding short-term risk, KLIN.SW is less volatile compared to BYS.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BYS.SW's competition here
KLIN.SW vs KOMN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, KOMN.SW has a market cap of 571.8M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while KOMN.SW trades at CHF 111.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas KOMN.SW's P/E ratio is -177.14. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to KOMN.SW's ROE of -0.01%. Regarding short-term risk, KLIN.SW is less volatile compared to KOMN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check KOMN.SW's competition here
KLIN.SW vs MEDX.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, MEDX.SW has a market cap of 488.2M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while MEDX.SW trades at CHF 11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas MEDX.SW's P/E ratio is -85.43. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to MEDX.SW's ROE of -0.02%. Regarding short-term risk, KLIN.SW is more volatile compared to MEDX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check MEDX.SW's competition here
KLIN.SW vs PMN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, PMN.SW has a market cap of 430.5M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while PMN.SW trades at CHF 460.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas PMN.SW's P/E ratio is 13.54. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to PMN.SW's ROE of +0.16%. Regarding short-term risk, KLIN.SW is more volatile compared to PMN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check PMN.SW's competition here
KLIN.SW vs PM.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas PM.SW's P/E ratio is 10.47. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to PM.SW's ROE of +0.16%. Regarding short-term risk, KLIN.SW is more volatile compared to PM.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check PM.SW's competition here
KLIN.SW vs MTG.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, MTG.SW has a market cap of 377.6M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while MTG.SW trades at CHF 36.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas MTG.SW's P/E ratio is 19.54. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to MTG.SW's ROE of +0.12%. Regarding short-term risk, KLIN.SW is more volatile compared to MTG.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check MTG.SW's competition here
KLIN.SW vs NOEJ.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, NOEJ.SW has a market cap of 367.1M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while NOEJ.SW trades at CHF 73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas NOEJ.SW's P/E ratio is 43.89. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to NOEJ.SW's ROE of +0.00%. Regarding short-term risk, KLIN.SW is more volatile compared to NOEJ.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check NOEJ.SW's competition here
KLIN.SW vs MIKN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, MIKN.SW has a market cap of 304.9M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while MIKN.SW trades at CHF 18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas MIKN.SW's P/E ratio is 9.58. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to MIKN.SW's ROE of +0.13%. Regarding short-term risk, KLIN.SW is more volatile compared to MIKN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check MIKN.SW's competition here
KLIN.SW vs RIEN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, RIEN.SW has a market cap of 280.3M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while RIEN.SW trades at CHF 62.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas RIEN.SW's P/E ratio is -25.10. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to RIEN.SW's ROE of +0.03%. Regarding short-term risk, KLIN.SW is more volatile compared to RIEN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check RIEN.SW's competition here
KLIN.SW vs STGN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, STGN.SW has a market cap of 185.9M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while STGN.SW trades at CHF 34.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas STGN.SW's P/E ratio is -49.57. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to STGN.SW's ROE of +0.04%. Regarding short-term risk, KLIN.SW is less volatile compared to STGN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check STGN.SW's competition here
KLIN.SW vs FTON.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, FTON.SW has a market cap of 180.4M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while FTON.SW trades at CHF 12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas FTON.SW's P/E ratio is -4.03. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to FTON.SW's ROE of -0.09%. Regarding short-term risk, KLIN.SW is more volatile compared to FTON.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check FTON.SW's competition here
KLIN.SW vs TOHN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to TOHN.SW's ROE of +0.04%. Regarding short-term risk, KLIN.SW is less volatile compared to TOHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check TOHN.SW's competition here
KLIN.SW vs STRN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, STRN.SW has a market cap of 25M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while STRN.SW trades at CHF 22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas STRN.SW's P/E ratio is 16.14. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to STRN.SW's ROE of +0.04%. Regarding short-term risk, KLIN.SW is more volatile compared to STRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check STRN.SW's competition here
KLIN.SW vs PEDU.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, PEDU.SW has a market cap of 6.2M. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while PEDU.SW trades at CHF 51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas PEDU.SW's P/E ratio is -3.58. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to PEDU.SW's ROE of -0.01%. Regarding short-term risk, KLIN.SW is less volatile compared to PEDU.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check PEDU.SW's competition here
KLIN.SW vs BOBNN.SW Comparison July 2025
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 113.6M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, KLIN.SW is priced at CHF 12.85, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of 12.12, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, KLIN.SW's ROE is +0.10%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, KLIN.SW is less volatile compared to BOBNN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BOBNN.SW's competition here